Home3EE0 • FRA
add
Novakand Pharma AB
Previous close
€0.00010
Day range
€0.00010 - €0.00010
Year range
€0.00010 - €0.16
Market cap
12.61M SEK
Avg Volume
1.04K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
New York Post
55 minutes ago
Dow sinks 400 points, oil heads to $90 as Iran war fears grip Wall Street
2.77%
0.83%
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.01M | -49.43% |
Net income | -4.97M | 48.45% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.07M | -65.33% |
Total assets | 16.73M | -74.99% |
Total liabilities | 1.67M | -63.83% |
Total equity | 15.06M | — |
Shares outstanding | 121.19M | — |
Price to book | 0.00 | — |
Return on assets | -62.77% | — |
Return on capital | -71.40% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.97M | 48.45% |
Cash from operations | -6.19M | 46.45% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -6.19M | 46.45% |
Free cash flow | -4.36M | 46.33% |
About
Website
Employees
5
